JP2023510965A5 - - Google Patents
Info
- Publication number
- JP2023510965A5 JP2023510965A5 JP2022544104A JP2022544104A JP2023510965A5 JP 2023510965 A5 JP2023510965 A5 JP 2023510965A5 JP 2022544104 A JP2022544104 A JP 2022544104A JP 2022544104 A JP2022544104 A JP 2022544104A JP 2023510965 A5 JP2023510965 A5 JP 2023510965A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pellet
- arthritis
- methotrexate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20153818.8 | 2020-01-27 | ||
| EP20153818.8A EP3854385A1 (en) | 2020-01-27 | 2020-01-27 | Methotrexate dosage form |
| PCT/DK2021/050025 WO2021151442A2 (en) | 2020-01-27 | 2021-01-26 | Methotrexate dosage form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510965A JP2023510965A (ja) | 2023-03-15 |
| JP2023510965A5 true JP2023510965A5 (https=) | 2024-01-10 |
Family
ID=69326391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544104A Pending JP2023510965A (ja) | 2020-01-27 | 2021-01-26 | メトトレキサート投薬形態 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230051463A1 (https=) |
| EP (2) | EP3854385A1 (https=) |
| JP (1) | JP2023510965A (https=) |
| CA (1) | CA3163555A1 (https=) |
| WO (1) | WO2021151442A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
| CN119235808A (zh) * | 2024-11-21 | 2025-01-03 | 江苏知原药业股份有限公司 | 一种甲氨蝶呤包衣片及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2271560C (en) * | 1996-11-15 | 2003-09-23 | Mayo Foundation For Medical Education And Research | Pharmaceutical dosage form for colonic delivery |
| CN1283991A (zh) * | 1997-12-03 | 2001-02-14 | 藤泽药品工业株式会社 | 软质颗粒状药剂以及它的制造方法 |
| US7662864B2 (en) * | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| US20050101605A1 (en) * | 2003-11-07 | 2005-05-12 | Ahmed Salah U. | Oral liquid formulations of methotrexate |
| US8007827B2 (en) | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| US20060039985A1 (en) * | 2004-04-27 | 2006-02-23 | Bennett David B | Methotrexate compositions |
| WO2006122414A1 (en) * | 2005-05-17 | 2006-11-23 | Matregen Corp. | Depot for sustained and controlled delivery of methotrexate |
| US20080268045A1 (en) * | 2006-11-09 | 2008-10-30 | Proprius Pharmaceuticals, Inc. | Sustained release methotrexate formulations and methods of use thereof |
| EP2278999B1 (en) * | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Auris formulations for treating otic diseases and conditions |
| WO2010065491A2 (en) * | 2008-12-01 | 2010-06-10 | Carolus Therapeutics, Inc. | Methods of treating inflammatory disorders |
| CN103417544B (zh) * | 2012-05-22 | 2017-07-14 | 欣凯医药化工中间体（上海）有限公司 | 甲氨叶酸复方制剂及其制备方法和用途 |
| HRP20190173T1 (hr) * | 2013-03-08 | 2019-03-22 | Novartis Ag | Oralne formulacije deferasiroksa |
| GB201419261D0 (en) * | 2014-10-29 | 2014-12-10 | Therakind Ltd | Formulations |
| AU2017297718B2 (en) | 2016-07-11 | 2023-06-08 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
| CN107714653B (zh) * | 2017-11-27 | 2022-01-28 | 济南新科医药科技有限公司 | 一种稳定的可溶性甲氨蝶呤颗粒剂 |
-
2020
- 2020-01-27 EP EP20153818.8A patent/EP3854385A1/en not_active Withdrawn
-
2021
- 2021-01-26 JP JP2022544104A patent/JP2023510965A/ja active Pending
- 2021-01-26 CA CA3163555A patent/CA3163555A1/en active Pending
- 2021-01-26 WO PCT/DK2021/050025 patent/WO2021151442A2/en not_active Ceased
- 2021-01-26 EP EP21703828.0A patent/EP4096641A2/en active Pending
- 2021-01-26 US US17/789,698 patent/US20230051463A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7398999B2 (ja) | 薬物動態が改善された放出調節ガンマ－ヒドロキシ酪酸塩製剤 | |
| JP4077320B2 (ja) | ５−メチル−１−フェニル−２−（１ｈ）−ピリドンを有効成分として含有する医薬製剤 | |
| ES2337547T3 (es) | Composiciones de liberacion controlada que contienen nimesulida. | |
| ES2708955T3 (es) | Formulaciones orales de deferasirox | |
| JP6216325B2 (ja) | 医薬製剤 | |
| CN105431144A (zh) | 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合 | |
| JP2022533368A5 (https=) | ||
| JP2022535893A5 (https=) | ||
| CN111202731B (zh) | 联合用药应用以及一种药用组合物及其应用 | |
| CN105338970B (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| JP2023510965A5 (https=) | ||
| JP2021075530A (ja) | 医薬組成物 | |
| JP6260736B1 (ja) | 固形製剤 | |
| JP7198575B2 (ja) | メマンチン塩酸塩含有口腔内崩壊錠 | |
| ES2197676T3 (es) | Composiciones farmaceuticas que comprenden ibuprofeno y domperidona. | |
| JP2019532960A (ja) | エソメプラゾール含有複合カプセル剤及びその製造方法 | |
| JP2022540348A5 (https=) | ||
| CN104622791A (zh) | 地佐辛口服制剂 | |
| KR20160076928A (ko) | 푸마르산 에스테르를 함유하는 미니-정제 형태의 약제학적 제제 | |
| CN105025883A (zh) | 右哌甲酯或其盐的调节释放的药物组合物 | |
| JP2021075529A (ja) | 医薬組成物 | |
| ES2693156T3 (es) | Comprimido de liberación sostenida que contiene levodropropizina y método para prepararlo | |
| KR101093781B1 (ko) | ｐＨ조절제를 함유하는 목시플록사신 고형 조성물 | |
| WO2019209217A2 (en) | Modified release formulations of flurbiprofen | |
| AU2001283191A1 (en) | Compositions containing an inhibitor of dihydrofolate reductase and a folate |